Transforming growth factor beta and bone morphogenetic protein actions in brain tumors
2015 (English)In: FEBS Letters, ISSN 0014-5793, E-ISSN 1873-3468, Vol. 589, no 14, 1588-1597 p.Article, review/survey (Refereed) Published
Members of the transforming growth factor beta (TGF-beta) family are implicated in the biology of several cancers. Here we focus on malignancies of the brain and examine the TGF beta and the bone morphogenetic protein (BMP) signaling branches of the family. These pathways exhibit context-dependent actions during tumorigenesis, acting either as tumor suppressors or as pro-tumorigenic agents. In the brain, the TGF-beta s associate with oncogenic development and progression to the more malignant state. Inversely, the BMPs suppress tumorigenic potential by acting as agents that induce tumor cell differentiation. The latter has been best demonstrated in grade IV astrocytomas, otherwise known as glioblastoma multiforme. We discuss how the actions of TGF-beta s and BMPs on cancer stem cells may explain their effects on tumor progression, and try to highlight intricate mechanisms that may link tumor cell differentiation to invasion. The focus on TGF-beta and BMP and their actions in brain malignancies provides a rich territory for mechanistic understanding of tumor heterogeneity and suggests ways for improved therapeutic intervention, currently being addressed by clinical trials.
Place, publisher, year, edition, pages
2015. Vol. 589, no 14, 1588-1597 p.
Bone morphogenetic protein, Brain, Cancer, Differentiation, Glioma, Transforming growth factor beta
Cancer and Oncology
IdentifiersURN: urn:nbn:se:uu:diva-257522DOI: 10.1016/j.febslet.2015.04.058ISI: 000355635900010OAI: oai:DiVA.org:uu-257522DiVA: diva2:839607